The Biden administration is putting pharmaceutical companies on notice, warning them that if the price of certain drugs is too high, the government might cancel their patent protection and allow rivals to make their own versions.
With health care costs in mind, the administration also sent a warning Thursday to private equity firms that have been buying up and gutting hospitals and physician practices around the country, then selling for a profit.
#Biden administration #pharmaceutical companies #drug prices #patent protection #private equity firms #healthcare costs
[
add
]
[
|
|
...
]